Showing results (2871-2880 of 9,184) with videos related to
Sort By:
Pageof 919
Cancer Medicine|January 29, 2020
Daratumumab prevents programmed death ligand-1 expression on antigen-presenting cells in de novo multiple myelomaNicolas Stocker, Béatrice Gaugler, Laure Ricard, et al.Cancer Medicine|January 29, 2020
Identify potential clinical significance of long noncoding RNA forkhead box P4 antisense RNA 1 in patients with early stage pancreatic ductal adenocarcinomaXiao-Guang Liu, Hao Xu, Ming Chen, et al.Cancer Medicine|January 29, 2020
Patterns of care for older patients with stage IV non-small cell lung cancer in the immunotherapy eraKenneth L Kehl, Michael J Hassett, Deborah SchragCancer Medicine|November 21, 2020
Fatherhood status in relation to prostate cancer risks in two large U.S.-based prospective cohort studiesAshley M Geczik, Scott P Kelly, Ruth M Pfeiffer, et al.Cancer Medicine|October 23, 2020
Screening and bioinformatics analysis of a ceRNA network based on the circular RNAs, miRNAs, and mRNAs in pan-cancerZhanghan Chen, Jie Huang, Yanling Feng, et al.Cancer Medicine|October 24, 2020
Gene signature based on B cell predicts clinical outcome of radiotherapy and immunotherapy for patients with lung adenocarcinomaLinzhi Han, Hongjie Shi, Yuan Luo, et al.Cancer Medicine|November 7, 2020
Work changes and individual, cancer-related, and work-related predictors of decreased work participation among African American cancer survivorsTheresa A Hastert, Anne C Kirchhoff, Matthew P Banegas, et al.Cancer Medicine|November 8, 2020
Ambient carbon monoxide exposure and elevated risk of mortality in the glioblastoma patients: A double-cohort retrospective observational studySeon-Jin Yoon, Juhwan Noh, Hye Young Son, et al.Cancer Medicine|November 10, 2020
Real-world experience of carfilzomib-associated cardiovascular adverse events: SEER-Medicare data set analysisRohit Bishnoi, Zhigang Xie, Chintan Shah, et al.Cancer Medicine|October 31, 2020
Pamiparib dose escalation in Chinese patients with non-mucinous high-grade ovarian cancer or advanced triple-negative breast cancerBinghe Xu, Yongmei Yin, Mei Dong, et al.Pageof 919